| http://www.w3.org/ns/prov#value | - function.Past or current anti-cancer treatment except corticosteroids during less than one week.Tumor cell negative for CD20Prior exposure to rituximab.Severe active viral infection, especially hepatitis B.Hepatitis B carrier status history of HBV or positive serology.Participation in another investigational drug clinical trial.Patients who, for any reason, are not able to comply with the nationa
|
